The UK Sepsis Trust project on the assessment and prioritisation of patients at risk of neutropenic sepsis.
The UK Sepsis Trust are leading a project with 52 North Health, focused on the assessment and prioritisation of patients at risk of neutropenic sepsis. As a member of our organisation, you have been identified as a Subject Matter Expert (SME) in this field and are invited to participate in the project.
52North Health is Cambridge based med-tech company developing cutting-edge technologies to support remote monitoring and healthcare. Their solution, Neutrocheck®, is a home-use, low-cost, portable, and easy-to-use medical device and app that can identify patients at risk of neutropenic sepsis.
The project will be run as a Delphi study, a methodology designed to transform opinion amongst a group of experts into group consensus. This can be used to deliver practical guidance and inform policy change. The aim of the study is to build consensus on elements of triage and early treatment pathways of patients with potential neutropenic sepsis.
Your views and perspectives would be very much valued in this project.
Participation will require completing an online survey at 3 separate time intervals. The Surveys should take no longer than 10 minutes to complete each round.
If you would like to find out more about this study or express interest in joining as an SME please scan the QR code below or follow this link: Study info & expression of interest